E.E. Geduld’s Kite Pharma, Inc. KITE Stock Holding History

E.E. Geduld’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,000	Closed	-$288K	–	326
2015 Q1	$288K	Sell	5,000 -10,000	-67%	-$670K	0.19%	124
2014 Q4	$865K	Buy	+15,000	New	+$632K	0.47%	30

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

E.E. Geduld's KITE Position: Q2 2015 in Review

E.E. Geduld sold out of Kite Pharma, Inc. (KITE) in Q2 2015, closing a stake of 5,000 shares — an estimated $288K sold.

E.E. Geduld first reported a position in KITE in Q4 2014 and held it in 2 quarters. The position peaked at $865K in Q4 2014. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

E.E. Geduld reported no remaining Kite Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
E.E. Geduld sold 5,000 Kite Pharma, Inc. shares in Q2 2015, an estimated $288K.
E.E. Geduld first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 2 quarters.
E.E. Geduld's Kite Pharma, Inc. position peaked at $865K in Q4 2014.
155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.